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Oysters from a harvesting area responsible for out-
breaks of gastroenteritis were relaid at a clean sea-
water site and subsequently depurated in tanks of 
purified seawater at elevated temperatures. This com-
bined treatment reduced norovirus levels to those 
detected prior to the outbreak. On the basis of noro-
virus monitoring the sale of treated oysters was per-
mitted although the harvest area remained closed for 
direct sale of oysters. No reports of illness have been 
associated with the consumption of treated oysters.
Oysters are filter-feeding bivalve molluscs which may 
become contaminated with human pathogens when 
grown in sewage-contaminated waters, which can lead 
to illness as the oysters are often consumed raw. In 
Europe, regulations are in place to prevent this risk 
[1]. Shellfish harvesting areas are classified into three 
categories (A, B or C) depending on the extent of fae-
cal contamination of the area as judged by levels of 
Escherichia coli. Shellfish treatments are prescribed 
depending on the classification. Despite these controls 
outbreaks of illness associated with oyster consump-
tion continue, in particular outbreaks of gastroenteritis 
associated with norovirus (NoV)-contaminated oysters. 
Until recently, suitable methods for the quantitative 
detection of NoV in shellfish have not been available. 
A high prevalence of NoV in oysters from a range of 
harvesting areas throughout Europe has been shown 
by PCR [5-7]. Quantitative real-time PCR procedures are 
currently undergoing standardisation at the European 
level (CEN WG6 TAG4). Where quantitative data exists, 
NoV levels detected in shellfish harvest areas are often 
low and near the detection limit [8,9]. The public health 
significance of oysters containing low levels of NoV is 
unclear. 
Various intervention steps are available to reduce the 
microbiological load in sewage-contaminated shell-
fish. These include relaying shellfish in clean seawater 
areas to allow them to purge contaminants. A similar, 
more controlled process is performed in tanks of sea-
water purified by disinfection. This process is called 
depuration and is used extensively throughout Europe. 
Depuration is commonly carried out for 24 to 48 hours 
at ambient temperatures. It has been demonstrated to 
eliminate bacteria from shellfish but has little impact 
on virus levels in oysters [10,11]. However, depura-
tion carried out at elevated temperatures (17-20 oC) for 
extended periods of three to five days reduces virus 
levels in oysters significantly [12,13].
NoV generally causes a relatively mild gastroenteritis 
in most people that is significantly under-reported and 
often recognised only in outbreak situations. In recent 
months an unusually high number of NoV gastroen-
teritis outbreaks associated with the consumption of 
shellfish have been reported in Europe [14]. It is likely 
that the recent high incidence of oyster-associated out-
breaks with is connected the unusually cold weather in 
2010. 
Norovirus outbreaks
Over a five week period in January and February 2010, 
more than 70 cases of gastroenteritis in Ireland and 
the United Kingdom (UK) were due to the consumption 
of oysters originating from an Irish harvesting area. 
The infections in England have been recorded as part 
of a wider report on European-wide outbreaks [14]. 
Oysters connected to two illness incidents in Ireland 
were available for testing and contained 2,040 and 
2,350 NoV genome copies per g, respectively. 
Table
Norovirus GII levels in oysters from the harvest area, Ireland, 2009
Date 2009 20/01 25/02 26/04 19/05 05/07 11/08 09/11 13/12
Genome copies per g 219 <LOQ <LOQ ND ND ND 1,280 278
LOQ: limit of quantitation (100 virus genome copies per g); ND not detected.
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Following reports of illness two companies produc-
ing oysters from the affected harvest area voluntarily 
ceased production on 10 February and implemented a 
recall of product already on the market. On 12 February 
a formal compliance notice was issued by the compe-
tent authority in Ireland the harvest area was closed 
for direct sale of oysters. Prior to the outbreak limited 
data was available regarding NoV levels in oysters 
from this harvest area which to our knowledge was not 
associated with any reports of illness in 2009. 
We report the use of relaying combined with extended 
depuration at elevated temperatures to reduce NoV in 
oysters of the harvesting area and highlight the poten-
tial of quantitative real-time PCR for monitoring treat-
ment processes for oysters and more accurately assess 
the risk to consumers. 
Methods 
Treatment and sampling
On 26 February oysters from the harvest area were 
relaid in an area believed to be free from sewage con-
tamination. Relaid shellfish were monitored for NoV 
levels at least once a week. On 15 March oysters from 
the relay site were further treated by depuration at 
elevated temperature (15-170C) for a period of at least 
four days. Subsequent batches of relaid shellfish were 
depurated using the same treatment regime. 
Samples of 24 whole oysters were transported to the 
laboratory within 24 hours of sampling under chilled 
conditions and analysed for NoV genogroup I (GI) and 
genogroup II (GII) within 24 hours of receipt in the 
laboratory.
Detection and quantification of 
norovirus by real-time PCR
Virus extraction was undertaken as described previ-
ously [15] followed by RNA extraction based on the 
Boom method [16] using NucliSens Magnetic Extraction 
reagents (Biomerieux). NoV RNA was then detected 
by reverse transcription (RT) quantitative real-time 
PCR employing primers and probes specific for NoV 
GI [17,18] and GII [19,20]. Real-time PCR controls were 
used to evaluate extraction efficiency [21] and amplifi-
cation efficiency [17,18].
Results
During 2009, eight samples of oysters from the area 
had been analysed for NoV. These data had been col-
lected retrospectively as part of a wider survey to 
determine background levels of NoV in shellfish har-
vest areas and results were not intended for regulatory 
control. Levels ranged from not detectable to 1,280 
viral genome copies per g (Table). 
Throughout the period of NoV monitoring following 
the outbreak in February and March 2010, NoV GI was 
detected in two samples from the harvest area. On 
both occasions levels were below the limit of quantita-
tion of the assay (100 viral genome copies per g). NoV 
GI was not detected in any samples from the relay site 
or in samples taken during the depuration period. 
NoV GII levels in nine samples of oysters from the har-
vest area between 9 February and 15 March 2010 are 
shown in Figure 1. During this period in the norovirus 
load in the oysters did not decrease and ranged from 
1,100 to 2,900 viral genome copies per g. 
In oysters relaid from the harvest area to clean seawa-
ter, NoV GII levels decreased from 2,900 to 492 viral 
genome copies in a 17-day period from 26 February 
to 15 March (Figure 2). Subsequent depuration of the 
relaid shellfish at 17 0C reduced NoV GII levels to 136 
viral genome copies per g after four  days and to below 
the limit of quantitation of the assay (100 viral genome 
copies per g) after six days.
Subsequently, during the period from 29 March to 12 
April, a further four batches of oysters which had been 
relaid since the 26 February have been depurated. 
Each depuration cycle was performed for between four 
and eight days at temperatures between 15 and 17 0C 
and reduced the levels of NoV GII to below 200 viral 
genome copies per g. 
Figure 2
Norovirus levels in oysters from the main harvest area 
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The oysters responsible for the outbreak described 
here originated from a category A classified water 
with E. coli levels consistently below 230 MPN (most 
probable number) per 100 g. Oysters from category A 
areas are approved for consumption without treatment. 
In practice, oysters from this harvest area were depu-
rated at ambient temperature before sale. However it is 
well documented that depuration at low temperatures 
has little impact on reducing virus levels in shellfish 
[10,22]. The recent outbreaks of NoV infection associ-
ated with consumption of oysters from this harvest-
ing site confirm the inadequacy of the current control 
measures and treatment processes to fully protect con-
sumers in Europe.
Low levels of NoV are commonly detected in oysters, 
particularly during the winter months. A limited data 
set from 2009 suggests that NoV levels in oysters from 
the harvest area in question are also generally low. 
No reports of illness associated with this area were 
recorded during this period. In January and February 
2010 however, the levels of NoV increased signifi-
cantly, probably due to the seasonally high level of the 
virus in the human population and the particularly cold 
temperatures. This increase in NoV levels was clearly 
associated with outbreaks of NoV gastroenteritis in 
consumers. In response the competent authorities in 
Ireland closed the harvest area for direct sale of oys-
ters and it remains closed at the time of publication of 
this report.
To facilitate the sale of oysters from the harvest area, 
treatment options were considered and validated by 
real-time PCR monitoring. Previous studies have dem-
onstrated that NoV may persist following treatment 
such as relaying and depuration [10,22]. The data pre-
sented here demonstrate that relaying of oysters for 17 
days in a clean seawater site followed by a minimum 
of four days purification at temperatures of 15-170C 
reduced the NoV load to background levels detected in 
the harvest area before the gastroenteritis incidents. 
On this basis the risk to consumers was considered 
negligible, and while the main harvest area remained 
closed for direct sale, oysters treated in the described 
way since 26 February have been allowed on the mar-
ket. Since 19 March 2010 more than 50,000 oysters 
have been placed on the market and no reports of ill-
ness have been received. NoV levels in these batches 
were less than 200 viral genome copies per g.
Limited data are available on the levels of NoV in oys-
ters that have caused outbreaks. Recently two reports 
of large outbreaks have demonstrated high NoV levels 
(possibly >8,000 viral genome copies per g) in oysters 
from the harvest areas involved [9,23]. Although the 
NoV dose required to cause infection may be as low as 
10 to 100 infectious particles [24] and sporadic cases 
may be caused by oysters with low NoV levels, the two 
reports and our results would suggest that relatively 
high levels of NoV (possibly >1000 viral genome copies 
per g) are required to cause significant outbreaks of 
illness. This may be consistent with a dose response 
pattern described in human volunteer studies inves-
tigating Norwalk virus (GGI.I) that indicated that 
3.24x103 genome copies of NoV GGI.I were required 
before illness was observed [25]. In addition it has been 
suggested that PCR may overestimate the level of via-
ble virus particles in shellfish and this should be taken 
into account when considering the risk associated with 
oyster consumption. There is growing evidence that 
it is possible to distinguish the relative risk of illness 
based on the level of NoV in the oysters. Given the cur-
rent inadequacy of controls based on E. coli standards 
we believe that the introduction of an appropriate virus 
standard would have a positive public health benefit.
We believe that NoV monitoring of at-risk oyster har-
vesting areas and the introduction of an upper limit 
for NoV in oysters could prevent a significant number 
of outbreaks associated with oyster consumption in 
Europe. Validated treatment processes such as relay-
ing and depuration at elevated temperatures can be 
used to produce oysters which are safe to consume 
despite the fact that low levels of NoV, as detected by 
real-time PCR, remain in the treated oysters.
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